Evidence map›Paper›PMID 38444580›Full record

ArticleJIMD reports2024

Specific GAG ratios in the diagnosis of mucopolysaccharidoses.

Déborah Mathis, Jean-Christophe Prost, Gabriela Maeder, Liya Arackal, Haoyue Zhang, Sandra Kurth, Katrin Freiburghaus, Jean-Marc Nuoffer

Open access · goldAbstract read
In one paragraph

Article in JIMD reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Déborah MathisUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern Bern Switzerland.ORCID https://orcid.org/0000-0002-2326-7782
Jean-Christophe ProstUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern Bern Switzerland.
Gabriela MaederUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern Bern Switzerland.
Liya ArackalUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern Bern Switzerland.
Haoyue ZhangBiochemical Genetics Laboratory Duke University Health System Durham North Carolina USA.
Sandra KurthUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern Bern Switzerland.
Katrin FreiburghausUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern Bern Switzerland.
Jean-Marc NuofferUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern Bern Switzerland.
University of Bern · CHDuke University Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucopolysaccharidoses (MPS) screening is tedious and still performed by analysis of total glycosaminoglycans (GAG) using 1,9-dimethylmethylene blue (DMB) photometric assay, although false positive and negative tests have been reported. Analysis of differentiated GAGs have been pursued classically by gel electrophoresis or more recently by quantitative LC-MS assays. Secondary elevations of GAGs have been reported in urinary tract infections (UTI). In this manuscript, we describe the diagnostic accuracy of urinary GAG measurements by LC-MS for MPS typing in 68 untreated MPS and mucolipidosis (ML) patients, 183 controls and 153 UTI samples. We report age-dependent reference values and cut-offs for chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS) and keratan sulfate (KS) and specific GAG ratios. The use of HS/DS ratio in combination to GAG concentrations normalized to creatinine improves the diagnostic accuracy in MPS type I, II, VI and VII. In total 15 samples classified to the wrong MPS type could be correctly assigned using HS/DS ratio. Increased KS/HS ratio in addition to increased KS improves discrimination of MPS type IV by excluding false positives. Some samples of UTI patients showed elevation of specific GAGs, mainly CS, KS and KS/HS ratio and could be misclassified as MPS type IV. Finally, DMB photometric assay performed in MPS and ML samples reveal four false negative tests (sensitivity of 94%). In conclusion, specific GAG ratios in complement to quantitative GAG values obtained by LC-MS enhance discrimination of MPS types. Exclusion of patients with UTI improve diagnostic accuracy in MPS IV but not in other types.

Indexed as

chondroitin sulfatedermatan sulfatediagnosisdimethylmethylene blue dye‐binding (DMB) assayGAGglycosaminoglycansheparan sulfatekeratan sulfateLC–MSMPSmucopolysaccharidosisratiosreference valuesurinary tract infection

Identifiers

PMID38444580
PMCPMC10910216
OpenAlexW4391646857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.